Perseus Proteomics Inc., a University of Tokyo startup, and Kyorin Pharmaceutical Co., Ltd. have reportedly begun joint research into a novel therapeutic drug. Progress in the research will be closely watched.
Perseus Proteomics Inc. and Kyorin Pharmaceutical Co., Ltd. have begun joint research aimed at developing a novel therapeutic drug related to antibody-based medicines. The article first reports the start of this joint research.
The article does not provide details of the specific fields or therapeutic areas targeted by the joint research, but reports that the two companies plan to jointly pursue the development of a novel therapeutic drug.